Trial intelligence / Profile preview

Senno Trial: 1L PEG-ascorbic acid with sennoside vs 2L PEG-ascorbic acid for colonoscopy bowel preparation

jRCT1051220043Completed

Start
Jun 2022
Modality
Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of macrogol, ascorbic acid and sennosid A + sennosid B (2 arms). Primary endpoint: Inadequate bowel preparation rate. Started Jun 2022; status: completed.

02

Drugs

macrogolascorbic acidsennosid A + sennosid B

Beyond the preview

Go deeper on jRCT1051220043.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1051220043.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call